Diclon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diclon

Quick Facts

Property Description
Active ingredient Diclofenac (Sodium or Potassium salt)
Form Tablets (various releases), Capsules, Injectable Solution, Topical Gels, Suppositories
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
General purpose Manages pain, reduces inflammation, and lowers fever
Origin Synthetic compound

Diclon: Identity and Pharmacological Class

Diclon is a trade name for a medicinal product containing the active ingredient Diclofenac, a globally recognized agent that belongs to the Non-Steroidal Anti-Inflammatory Drug (NSAID) class. This classification is precise, as NSAIDs are distinct from pure analgesics in that they simultaneously target the mechanisms of pain, fever, and inflammation. Diclofenac is a synthetic compound derived from phenylacetic acid.

As an active ingredient, Diclofenac functions as an inhibitor of cyclooxygenase, which is essential for its anti-inflammatory effects. This mechanism means the medicine directly helps reduce swelling and localized heat by controlling the body’s inflammatory response. Diclofenac is clinically recognized for its efficacy in managing inflammatory processes associated with general musculoskeletal discomfort.


Composition, Forms, and General Purpose

The core component, Diclofenac, is incorporated into various pharmaceutical preparations to allow for different applications. These include oral dosage forms such as tablets (often formulated for delayed or sustained-release), capsules, injectable forms like solution for intramuscular injection, rectal suppositories, and multiple topical preparations such as gels or creams. Diclofenac potassium is a differentiating factor often used when rapid pain management is the priority due to its faster absorption profile compared to the sodium salt.

While the drug is most often used as a single-ingredient product, some formulations may be developed as combination products integrating other active substances for enhanced effects. The fundamental general purpose of Diclofenac across all forms is to achieve symptomatic relief by reducing the three primary physiological responses of pain, inflammation, and fever. Diclofenac is utilized for its analgesic and anti-inflammatory properties in multiple physical forms. This confirms that the drug’s core value is its proven ability to ease discomfort and reduce swelling.

What side effects are possible with Diclon?

Safety Profile and Serious Adverse Reactions

Diclon, a non-steroidal anti-inflammatory drug (NSAID), is associated with a risk of serious adverse events primarily affecting the cardiovascular and gastrointestinal systems. These reactions can be fatal and may occur without warning.

Serious Risks and Contraindications

Cardiovascular (CV) Thrombotic Events: The drug carries an increased risk of serious CV thrombotic events, including myocardial infarction (heart attack) and stroke, particularly with higher doses and prolonged use. Diclon is generally contraindicated in the setting of coronary artery bypass graft (CABG) surgery and in patients with established congestive heart failure (NYHA Class II-IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease.

Gastrointestinal (GI) Events: Diclon can cause serious GI inflammation, bleeding, ulceration, and perforation of the stomach or intestines. This risk is higher in elderly patients and those with a prior history of GI disease. Use is contraindicated in patients with active GI bleeding or perforation.

Other Serious Reactions: Potential serious reactions also include hepatotoxicity (liver injury) requiring liver enzyme monitoring, renal toxicity (kidney injury), severe skin reactions (e.g., Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis), and severe hypersensitivity or anaphylactic reactions.

Common Side Effects

Commonly reported side effects for oral formulations include GI effects such as nausea, stomach pain, dyspepsia, diarrhea, and flatulence, along with headache, dizziness, and edema (fluid retention). Topical formulations generally carry a lower risk of systemic side effects, though localized skin reactions such as dermatitis are common.

Population-Specific Safety Notes

The lowest effective dose for the shortest duration should be used to minimize risks. Elderly patients are at greater risk for serious GI and renal adverse events. Diclon is contraindicated in the third trimester of pregnancy due to the risk of fetal cardiopulmonary toxicity and premature closure of the fetal ductus arteriosus. Patients with known risk factors, such as uncontrolled hypertension or diabetes, should be treated with extreme caution and require careful monitoring of blood pressure and renal function.

Overdose and Emergency Response

Overdose and When to Seek Help

Diclon overdose is officially classified based on the potential for acute multisystem toxicity, primarily involving the gastrointestinal (GI), central nervous (CNS), and renal systems. The regulatory profile documents that overdose may present with signs such as nausea, vomiting, abdominal pain, drowsiness, confusion, and ringing in the ears (tinnitus).

Overdose Manifestations Required Emergency Action
Gastrointestinal: Vomiting blood, bloody/tarry stools, severe abdominal pain. CNS: Confusion, seizures, or coma. Renal: Acute kidney failure or little/no urine output. Seek immediate medical attention. Contact emergency services or a Poison Control Center right away. This is mandatory for suspected overdose or any life-threatening symptoms.

The most serious outcomes documented include potentially fatal GI perforation, acute renal failure, and CNS depression leading to seizures or coma. Due to these risks, patients are instructed to contact help immediately if symptoms like chest pain, sudden weakness, or slurred speech occur. Management protocols are symptomatic and supportive, requiring hospital monitoring, as the official documentation confirms that no specific antidote is known. Special monitoring consideration is advised for patients with existing hepatic or renal impairment.

Therapeutic Uses of Diclon

Main Uses of Diclon

Diclon is a medication primarily used to manage pain and reduce inflammation. It belongs to a class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). By inhibiting specific enzymes in the body that produce prostaglandins—chemicals responsible for signaling pain and causing swelling—it helps alleviate symptoms associated with various musculoskeletal and inflammatory conditions.

Acute Pain and Inflammation

Diclon is commonly used for the short-term treatment of acute painful conditions. These may include:

  • Post-traumatic pain: Swelling and discomfort resulting from sprains, strains, or other minor injuries.
  • Post-operative pain: Management of inflammation and pain following surgical or dental procedures.
  • Menstrual pain: Relief of primary dysmenorrhea (painful periods).

Chronic Inflammatory Conditions

For long-term management, Diclon is utilized to reduce the persistent pain and stiffness associated with chronic joint disorders. Its anti-inflammatory properties are beneficial for:

  • Rheumatoid Arthritis: Reducing joint swelling and improving mobility in patients with this autoimmune condition.
  • Osteoarthritis: Alleviating pain caused by the degeneration of joint cartilage.
  • Ankylosing Spondylitis: Managing inflammation of the spine and large joints.

Other Applications

In certain formulations, Diclon may be used to treat other localized inflammatory issues, such as:

  • Soft tissue rheumatism: Conditions affecting tendons, ligaments, and muscles (e.g., tendonitis or bursitis).
  • Migraine attacks: Alleviating the intense headache and associated symptoms during acute episodes.

Benefits

The primary benefit of Diclon is the improvement of physical function and quality of life by reducing physical distress. By controlling inflammation, it helps to:

  • Decrease localized swelling and redness.
  • Restore range of motion in affected joints.
  • Provide effective relief from moderate to severe pain when non-pharmacological methods are insufficient.

Regulatory References

  1. NIH LiverTox on Diclofenac

Eligibility and Restrictions for Use

Who Can and Cannot Use Diclon?

Eligibility for Diclon (Diclofenac) is defined by official regulatory documents, specifying populations permitted, restricted, or prohibited from use.

Contraindications (Must Not Use)

Diclon is strictly contraindicated for several groups. This includes patients with a known hypersensitivity or history of allergic reactions, such as aspirin-sensitive asthma, to NSAIDs or any component of the formulation. It must not be used by patients in the setting of Coronary Artery Bypass Graft (CABG) surgery or by pregnant individuals starting from 30 weeks gestation (third trimester).

Condition-Based Restrictions

Use is restricted or avoided in patients with certain severe pre-existing conditions. Official labels advise avoiding use in patients with advanced renal disease, severe heart failure, or active gastrointestinal ulceration or bleeding unless benefits are documented to outweigh the significant risks. Patients with moderate hepatic impairment require caution and monitoring.

Age- and Life-Stage Eligibility

Age Group/Status Official Eligibility Status
Adults ( ge 18 years) Generally Approved
Pediatric Patients ( lt 12 years) Safety and effectiveness Not Established for most forms
Late Pregnancy ( ge 30 weeks) Contraindicated
Lactation Not Recommended

What should I know about interactions with other medicines?

Diclon Interactions with other medicines and products

Diclofenac's official interaction profile is defined by two primary types of constraints: additive risk and altered systemic exposure, as documented in governmental regulatory sources.

Interaction Scope

Category Description of Official Regulatory Constraint
Contraindicated Combinations Co-administration with other Systemic NSAIDs (including COX-2 inhibitors) and Analgesic Doses of Aspirin is officially prohibited due to the heightened risk of gastrointestinal (GI) adverse events. Use is also contraindicated in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Pharmacokinetic Effects The drug’s metabolism via the CYP2C9 enzyme means co-administration with inhibitors, such as Voriconazole, results in a documented increase in Diclofenac's systemic exposure (Cmax and AUC).
Exposure Modification Diclofenac can reduce the clearance of other medicines, leading to increased plasma concentrations of certain agents, including Lithium and Digoxin, which necessitates monitoring.
Pharmacodynamic Effects Interaction with Drugs that Interfere with Hemostasis (like Warfarin or SSRIs) increases the risk of bleeding and ulceration. Regulatory documents note the diminishment of the antihypertensive effect of ACE Inhibitors, ARBs, and Diuretics.
Substance & Population Notes Alcohol use is noted to increase the risk of GI bleeding. In patients who are Elderly or Volume Depleted, the renal risk associated with co-administering certain antihypertensives is heightened.

Connection to the overall interaction profile

Official regulatory documents define the Diclofenac interaction profile primarily through additive pharmacodynamic risk and pharmacokinetic interference involving altered drug clearance. This structure highlights explicit constraints, such as contraindicated combinations and the need for therapeutic monitoring of co-administered agents, as specified by governmental health authorities. The profile specifies which substances interact, the functional outcome of the interaction, and the necessary regulatory constraint. (198 words)

Mechanism of Action

How Diclon Works

Diclon's mechanism of action focuses on influencing activity within the lipid mediator signaling domain, specifically targeting the enzymatic pathways responsible for generating pro-inflammatory chemicals.

Core Mechanistic Domain: Cyclooxygenase (COX) Inhibition

Diclon acts as an inhibitor of the Cyclooxygenase (COX) enzymes, particularly COX-2, which are highly expressed in response to tissue stimuli. By blocking these enzymes, the drug prevents the conversion of arachidonic acid into prostanoids.

Effect on Prostaglandin Synthesis and Signaling

This inhibition suppresses the production of Prostaglandins, such as PGE2, a crucial molecule for activating pain receptors and elevating the hypothalamic temperature set-point. This mechanism modifies signaling within nociceptive and thermoregulatory pathways, which results in the attenuation of heightened signaling.

Central and Peripheral Action

The drug's dual scope engages biological systems in both the periphery (at the site of tissue injury) and the Central Nervous System (CNS), allowing it to reduce local inflammatory mediator production and affect central nociceptive and hypothalamic thermoregulatory pathways.

Dosage and Administration Information

How to Use Diclon: Official Administration Guidelines

The usage of Diclon (Diclofenac) is based on prescribing information, which details the appropriate routes, dosing, and conditions for administration. This guidance is centered on the principle of utilizing the lowest effective dosage for the shortest duration necessary.


Administration Routes and Dosing Patterns

The medicine is approved for multiple administration routes, including oral (tablets, capsules, powder), topical (gels, solutions), rectal (suppositories), and parenteral (intramuscular or intravenous injection). Dosing is form- and indication-specific, with standard oral adult doses ranging from 100 mg to 150 mg daily, typically divided. The maximum daily oral intake for some chronic indications may be up to 225 mg, but for acute parenteral use (IV/IM), the maximum is generally restricted to 150 mg per day for short-term use.

Administration Route Frequency Pattern Duration Constraint
Oral (Standard) Two to three times daily Shortest Duration Principle
Oral (Extended-Release) Once daily Maintenance Therapy Allowed
Parenteral (IV/IM) Once or twice daily Restricted to two days of acute use

Contextual and Handling Instructions

Administration often requires specific conditions. For example, the oral powder or certain capsules must be taken on an empty stomach after immediate mixing with water. Conversely, delayed-release or enteric-coated tablets must be swallowed whole and must not be crushed or chewed to preserve their intended release profile.

Guidelines indicate that dosage should be carefully selected for older adults, often necessitating the lowest possible dose. If a dose is missed, the patient should resume the scheduled administration at the next designated time and should not take a double dose to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Diclon

Chronic Inflammatory Conditions

The research base for Diclon was studied for chronic conditions, such as Osteoarthritis (OA), Rheumatoid Arthritis (RA), and Ankylosing Spondylitis (AS), in conditions where symptom management was explored. The evidence primarily consists of short-term Randomized Controlled Trials (RCTs) and Systematic Reviews. Studies explored how symptoms evolved in the observed populations over typical follow-up durations ranging from four to twelve weeks. Pooled data describe patterns observed in the studies related to patient-reported outcomes and functional measures over these short intervals.

A key limitation is that follow-up durations were limited in most initial trials. The evidence contributes to understanding short-term symptom patterns but data for long-term outcomes remain insufficient. Research is concentrated on outcomes related to physical discomfort rather than whether the medication was studied for its ability to alter the underlying disease course.

Acute and Episodic Pain States

Diclon was studied for acute and episodic conditions, which are conditions associated with acute or disruptive episodes, such as acute musculoskeletal pain (sprains and strains), migraine headaches, and primary dysmenorrhea (painful periods). Research examined the study objectives of Diclon, particularly in topical gel and rapid-release oral forms, in studies conducted during periods of increased symptom activity. These short-term RCTs monitored outcomes describing episodic or acute changes, such as the time needed to achieve a specific level of relief.

Evidence is limited in that results apply only to the specific populations studied, and follow-up durations were strictly short-term (hours to a few days) to capture the acute phase of symptoms. Research does not track the long-term recovery process of the underlying injury or assess use for the prevention of recurrent episodic symptoms, such as chronic migraine.

What Remains Uncertain in the Research Landscape

The evidence highlights what is known — and what is still uncertain — regarding the full research profile of Diclon. The primary limitation is that long-term effects are not fully established. Furthermore, the research predominantly focuses on outcomes related to symptomatic relief (such as pain and stiffness) and does not determine whether the medication impacts the underlying disease progression for conditions like RA or AS. Data for certain groups remain insufficient, particularly for pediatric populations and certain comorbidity-defined groups, as the results apply only to the adult populations studied in the official research.

Key Studies & References

  1. Diclofenac: MedlinePlus Drug Information (for general class and identity)
  2. Diclofenac: NIH LiverTox Clinical and Research Context

Frequently Asked Questions (FAQ)

Common questions about Diclon (FAQ)

Q: What's the difference between Diclon and common over-the-counter painkillers like ibuprofen or naproxen?

Official information confirms that Diclon belongs to the same class of medicines, called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), as ibuprofen and naproxen. Because they work similarly and share safety risks, regulatory documents advise against taking Diclon at the same time as other systemic NSAIDs. This combination may significantly increase the risk of serious side effects, and co-administration should be discussed with a healthcare professional.

Q: Can Diclon be used for both chronic, long-term conditions and acute, sudden pain?

Yes, regulatory documents and official research summaries indicate that Diclon is used for both chronic conditions and acute, sudden pain. It is studied for long-term conditions like osteoarthritis and rheumatoid arthritis, as well as short-term episodic pain states, such as acute musculoskeletal pain or migraine.

Q: Does taking Diclon with food or milk really help prevent stomach upset?

Some patient information suggests that taking Diclon with food or milk can help minimize common stomach upset. However, it is important to know that for certain immediate-release forms of the medicine, taking it with food may slightly delay its absorption. Patients are advised to follow the specific administration instructions provided for their form of the medication.

Q: What are the signs of a potential liver or kidney problem that could be caused by Diclon?

Diclon carries a risk of toxicity to the liver (hepatotoxicity) and kidneys (renal toxicity). Official labeling warns against use in patients with advanced renal disease and advises that monitoring may be required. If a patient experiences fever, rash, fatigue, or other signs of illness while taking this medication, they are advised to inform a healthcare professional.

Q: Does Diclon interact with any common herbal supplements or natural remedies?

Regulatory guidance often notes that there is insufficient evidence to confirm the safety of taking herbal remedies and natural supplements with Diclon. Since the interaction effects of these substances are not fully tested in the same way as prescription medicines, consultation with a healthcare professional is generally recommended before combining these products.

Q: Can Diclon cause an allergic reaction, and what does a serious reaction look like?

Yes, Diclon can cause severe hypersensitivity or anaphylactic reactions. According to regulatory labeling, signs of a serious reaction include sudden shortness of breath, swelling of the face, lips, or tongue, and a widespread rash or hives. If these signs are observed, seeking medical attention is required.

Q: What should I do if I notice my stools are black or tarry while taking Diclon?

Black, sticky, or tarry stools are a known sign of serious gastrointestinal bleeding, which is a risk associated with Diclon. If this symptom is observed, official guidance recommends discontinuing the medication and seeking immediate medical attention.

Q: How does Diclon compare to topical pain relief creams or gels in terms of side effects?

Regulatory information indicates that topical formulations of Diclon (creams or gels) generally carry a lower risk of systemic side effects (like heart or stomach issues) compared to oral tablets. However, topical use can commonly cause localized skin reactions like dermatitis at the application site.

Q: Can Diclon interact with certain antidepressant medications?

Yes, official labeling notes that Diclon can interact with certain types of antidepressants, specifically Selective Serotonin Reuptake Inhibitors (SSRIs). This combination is known to increase the overall risk of bleeding and ulceration, and caution is advised during co-administration.

Q: Why is Diclon sometimes prescribed with other medicines like paracetamol or a muscle relaxant?

Diclon may be formulated or prescribed alongside other substances like paracetamol (a common analgesic and fever reducer) in some cases. This is done to achieve an enhanced pain-relieving action, particularly for painful musculoskeletal conditions, by combining anti-inflammatory and analgesic effects.

Q: How long does it typically take to feel the pain-relieving effects of Diclon after taking a tablet?

Patient information from regulatory summaries suggests that Diclon tablets and capsules typically begin to work within 20 to 30 minutes after being taken. The actual time can vary depending on the specific formulation (e.g., immediate-release versus delayed-release) and whether it is taken with food.

Q: Is it normal to feel a bit dizzy or drowsy after taking Diclon?

Yes, some people may rarely experience side effects such as feeling tired, dizzy, or sleepy when taking Diclon. Due to these potential effects, patients are advised to use caution and avoid tasks requiring alertness, such as driving or operating machinery, until they know how the medication affects them.

Q: Is there a risk of stomach bleeding or ulcers with Diclon, especially with long-term use?

Yes, regulatory documents clearly state that the risk of serious gastrointestinal adverse events, including bleeding, ulceration, and perforation, is higher with increased dose and duration of use. These serious events can occur at any time during treatment, even without warning.

Q: Why is Diclon sometimes used as an eye drop, and how does it work in the eye?

The ophthalmic solution of Diclon is used as an eye drop to treat pain and swelling of the eye, commonly following procedures such as cataract surgery. It works as a topical Non-Steroidal Anti-Inflammatory Drug (NSAID) to reduce inflammation directly at the site of application in the eye.

Q: Is it true that Diclon can increase sensitivity to sunlight?

Yes, official regulatory labeling reports that cases of photosensitivity reactions (increased sensitivity and reaction to sunlight) have been reported with the use of Diclon. Patients are generally advised to take precautions against strong sun exposure.

Q: If I forget a dose of Diclon, what is the usual recommendation?

If a regular dose is missed, the recommendation found in official patient summaries is to take the missed dose as soon as the patient remembers. However, official information advises against taking a double dose to compensate for the forgotten one.

Q: Does Diclon affect fertility in men or women?

Regulatory summaries mention that taking anti-inflammatory medicines like Diclon, especially in large doses or for a long time, may affect ovulation in women. This temporary effect could potentially make it more difficult to conceive. Consultation with a healthcare provider is recommended for patients trying to become pregnant.

Q: Why do some people experience ringing or buzzing in their ears (tinnitus) with Diclon?

Ringing or buzzing in the ears, known as tinnitus, is a reported adverse effect. Regulatory labeling indicates that tinnitus has been noted, particularly in cases of overdose or excessive intake of the medication.

Q: Is it normal to have a mild skin rash when first using the Diclon topical cream or gel?

Yes, localized skin reactions at the application site are common with topical Diclon formulations. This can include dermatitis, which often presents as a mild skin rash, redness, or itching.

Q: Are there different forms of Diclon (e.g., tablet, gel, injection), and what are they used for?

Yes, Diclon is available in many forms, including oral tablets, capsules, suppositories, gels, patches, and solutions for injection. These forms are used to treat various conditions, such as arthritis, localized muscle pain, and acute post-surgical discomfort.

Q: Why does Diclon come in different formulations (like enteric-coated or sustained-release)?

Diclon is available in different formulations to control how and when the drug is released into the body. For example, enteric-coated tablets are designed to help protect the stomach lining, while sustained-release tablets are made to last longer in the body, often allowing for once-daily dosing.

Q: Can Diclon be used to treat a migraine attack that has already started?

Studies and regulatory summaries indicate that Diclon is effective and indicated for easing mild to moderate headaches and tension-type migraines. This confirms its role in treating migraine attacks that are already in progress.

Q: Is Diclon effective for period pain or primary dysmenorrhea?

Yes, official summaries confirm that Diclon is effective in reducing the pain associated with primary dysmenorrhea (period pain). It also has the added benefit of helping to reduce the amount of associated menstrual bleeding.

Q: What are the concerns about using Diclon during pregnancy or while breastfeeding?

Diclon is strictly contraindicated from the 30th week of gestation (third trimester) due to the risk of fetal harm. While only tiny amounts pass into breast milk, it is generally considered acceptable for short-term use during breastfeeding, though caution is advised.

Q: Is Diclon safe to use if I have an active infection or fever?

Diclon has fever-reducing properties, and regulatory guidance notes that, as an NSAID, it may mask the signs of an active infection. When taking this medicine with an infection, it is important for a healthcare professional to monitor the condition carefully.

Q: Is it necessary to have blood work done regularly if I take Diclon long-term?

Official labeling states that close medical surveillance is imperative for long-term use of Diclon. This often involves monitoring liver enzymes and kidney function to check for signs of toxicity, which may require regular blood tests.

Q: What is the recommendation for driving or operating machinery while on Diclon?

Because Diclon can rarely cause side effects such as tiredness, dizziness, sleepiness, or vision problems, regulatory warnings advise against driving or operating machinery until patients are certain the medicine does not cause these effects.

Q: How does Diclon help with gout pain and inflammation?

Diclon is indicated for the treatment of acute attacks of gout. It works by inhibiting the production of prostaglandins, which effectively reduces the severe inflammation and pain that characterize a gout attack.

How should Diclon be stored and disposed of?

How to Store and Dispose of Diclofenac (Diclon)

Storage Requirements

Diclofenac formulations must be stored within specific environmental and temperature constraints to ensure stability, as detailed in regulatory labeling.

Requirement Storage Conditions (Official Labeling)
Temperature Controlled Room Temperature: 20°C to 25°C (68°F to 77°F).
Handling Injectable solution must not be refrigerated or frozen and must be protected from light.
Container Oral tablets require the container to be kept tightly closed; injectable solutions must remain in the original container.
Child Safety Store all forms of the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Diclofenac must be discarded according to official instructions to protect the environment.

Official disposal rules require the product to be disposed of according to local regulations. The medicine should not be flushed down the toilet or poured into a drain; patients should consult a pharmacist or local waste management program about available drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diclon found in:

A-Z Index: